The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of VEGFR2 expression in tumor tissue with longer progression-free survival in patients with neuroendocrine tumors (NETs) treated with pazopanib.
Luis Ortega
No relevant relationships to disclose
Victor Reyes
No relevant relationships to disclose
Jaume Capdevila
No relevant relationships to disclose
Daniel E. Castellano
No relevant relationships to disclose
Rocio Garcia-Carbonero
No relevant relationships to disclose
Alex Teule
No relevant relationships to disclose
Ignacio Duran
No relevant relationships to disclose
Jose Fuster
No relevant relationships to disclose
Isabel Sevilla
No relevant relationships to disclose
Pilar Escudero
No relevant relationships to disclose
Javier Sastre
No relevant relationships to disclose
Jesús García-Donas
No relevant relationships to disclose
Teresa Alonso
No relevant relationships to disclose
Enrique Grande
No relevant relationships to disclose